Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs
The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
• Strong preference suggested by health care workers, clinicians who are deaf or hard of hearing, and general public • Transparent masks could be particularly helpful with those 65 and older Read More...
First human trial for intranasal vaccine for AD represents culmination of 20 years of research led at the Brigham Read More...
The studies highlighted below represent only a sample of the cutting-edge research that experts from Brigham and Women's Hospital will present at the conference Read More...
Connect with us.
Brigham and Womens Hospital
Media Relations, Office of Strategic Communications(617) 525-6370Available 24/7: (617) 732-6660pager #13160